Skip to the page

Data / Drug companies / Tapi Czech Industries S.r.o.

Tapi Czech Industries S.r.o.: 32 products in the FDA NDC directory, labeler code 84644

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Tapi Czech Industries S.r.o. (labeler code 84644) lists 32 products in the FDA National Drug Code Directory. By type: 32 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 17, 2026.

The request: Watch Tapi Czech Industries S.r.o. (FDA labeler code 84644): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84644
Products in commercial distribution
32
Packages
32
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 3, Schedule IV 1
Started marketing in the last 12 months
2
Earliest marketing start
January 22, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients32100%

Products by type

TypeProductsShare
Bulk ingredients32100%

Dosage forms

Dosage formProductsShare
Powder32100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Etrasimod l-arginine84644-066PowderBulk ingredientsJuly 17, 2026
Acoramidis hcl84644-065PowderBulk ingredientsJanuary 29, 2026
Ixazomib citrate84644-064PowderBulk ingredientsNovember 5, 2025
Pemetrexed diacid84644-026PowderBulk ingredientsNovember 5, 2025
Dabrafenib mesylate84644-063PowderBulk ingredientsJuly 9, 2025
Vilanterol trifenatate84644-054PowderBulk ingredientsNovember 7, 2024
Dihydroergotamine mesylate84644-006PowderBulk ingredientsNovember 7, 2024
Zavegepant hcl84644-062PowderBulk ingredientsDecember 14, 2023
Dihydroergotoxine mesylate84644-002PowderBulk ingredientsNovember 29, 2022
Voclosporin84644-059PowderBulk ingredientsApril 4, 2022
Ergonovine maleate84644-012PowderBulk ingredientsJanuary 26, 2022
Cyclosporine84644-004PowderBulk ingredientsJanuary 26, 2022
Ergotamine tartrate84644-001PowderBulk ingredientsJanuary 26, 2022
Palonosetron hydrochloride84644-027PowderBulk ingredientsJanuary 24, 2022
Mycophenolate mofetil84644-019PowderBulk ingredientsMay 14, 2021
Tacrolimus84644-018PowderBulk ingredientsMay 5, 2020
Pergolide mesylate84644-008PowderBulk ingredientsSeptember 3, 2019
Paliperidone palmitate84644-058PowderBulk ingredientsAugust 21, 2019
Fluticasone furoate84644-057PowderBulk ingredientsOctober 2, 2018
Methylergometrine maleate84644-021PowderBulk ingredientsJune 22, 2018
Bromocriptine mesylate micronize84644-003PowderBulk ingredientsDecember 29, 2017
Cabergoline84644-009PowderBulk ingredientsDecember 18, 2017
Paclitaxel semisynthetic84644-034PowderBulk ingredientsNovember 21, 2017
Umeclidinium bromide84644-055PowderBulk ingredientsNovember 8, 2016
Metopimazine84644-051PowderBulk ingredientsJanuary 12, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.